Cargando…
Gender difference in the response to valsartan/amlodipine single-pill combination in essential hypertension (China Status II): An observational study
BACKGROUND: The China STATUS II is a prospective, multicentre, open-label, post-marketing, observational study including Chinese adults (aged ⩾ 18 years) with essential hypertension who were prescribed once-daily valsartan/amlodipine (Val/Aml 80/5 mg) single-pill combination. In order to examine gen...
Autores principales: | Wang, Huan, Chen, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843875/ https://www.ncbi.nlm.nih.gov/pubmed/27127102 http://dx.doi.org/10.1177/1470320316643903 |
Ejemplares similares
-
Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II
por: Ge, Beihai, et al.
Publicado: (2015) -
Efficacy and Safety of Valsartan/Amlodipine Single-Pill Combination in 11,422 Chinese Patients with Hypertension: an Observational Study
por: Hu, Dayi, et al.
Publicado: (2014) -
Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014) -
Effectiveness and safety of valsartan/amlodipine in hypertensive patients with stroke: China Status II subanalysis
por: Zhang, Weiliang, et al.
Publicado: (2017) -
Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study
por: Assaad-Khalil, Samir H., et al.
Publicado: (2016)